RAPTA-C, CAS [[372948-28-2]] Preis auf Anfrage

Produktübersicht

• Artikelname: RAPTA-C, CAS [[372948-28-2]] Preis auf Anfrage
• Artikelnummer: MCE-HY-130326
• Hersteller Artikelnummer: HY-130326
• Alternativnummer: MCE-HY-130326-10MG,MCE-HY-130326-1MG,MCE-HY-130326-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Ru(eta6-p-cymene)Cl2(pta)

Produktbeschreibung

RAPTA-C (Ru(eta6-p-cymene)Cl2(pta)) acts as an anti-cancer and anti-angiogenic agent. RAPTA-C exhibits anti-metastatic, anti-angiogenic, and anti-tumoral activities through protein and histone-deoxyribonucleic acid alterations. RAPTA-C exhibits cell growth inhibition by triggering G(2)/M phase arrest in cancer cells. RAPTA-C also enhances the levels of p53 and triggers the mitochondrial Apoptotic pathway, resulting in cytochrome C release and caspase-9 activation. RAPTA-C reduces the growth of tumors with the inhibition of angiogenesis in a ovarian carcinoma model[1][2][3].

Produkteigenschaften

• Molekulargewicht: 460.32
• Reinheit: 99.30
• CAS Nummer: [372948-28-2]
• Formel: C16H23Cl2N3PRu
• Target-Kategorie: Apoptosis,Caspase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound